Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,031 | 41,739 | 64,886 | 121,330 | 80,576 |
| Marketable Securities | 20,161 | 72,416 | 71,648 | 26,004 | 87,188 |
| Receivables | 22,180 | 20,042 | 16,837 | 25,368 | 21,537 |
| Other current assets | 9,260 | 14,356 | 16,419 | 14,664 | 15,559 |
| TOTAL | $133,632 | $148,553 | $169,790 | $187,366 | $204,860 |
| Non-Current Assets | |||||
| PPE Net | 1,655 | 1,775 | 1,693 | 1,818 | 2,142 |
| Investments And Advances | 0 | 0 | 0 | 0 | 369 |
| Intangibles | 10,912 | 10,934 | 10,094 | 9,704 | 10,140 |
| Other Non-Current Assets | 591 | 3,971 | 3,721 | 3,747 | 2,788 |
| TOTAL | $13,158 | $16,680 | $15,508 | $15,269 | $15,439 |
| Total Assets | $146,790 | $165,233 | $185,298 | $202,635 | $220,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,993 | 14,311 | 18,812 | 16,399 | 18,561 |
| Other current liabilities | 301 | 457 | 392 | 306 | 3,255 |
| TOTAL | $17,379 | $14,768 | $19,264 | $16,822 | $21,997 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 55,348 | 56,310 | 53,291 | 51,790 | 75,376 |
| TOTAL | $55,348 | $56,310 | $53,291 | $51,790 | $75,376 |
| Total Liabilities | $72,727 | $71,078 | $72,555 | $68,612 | $97,373 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,234 | 141,702 | 141,691 | N/A | N/A |
| Common Shares | 10,290 | 10,290 | 10,289 | 10,288 | 9,211 |
| Retained earnings | -550,802 | -529,844 | -502,536 | -474,044 | -450,850 |
| Other shareholders' equity | -3,073 | -1,404 | -8,084 | -11,781 | 2,229 |
| TOTAL | $74,063 | $94,155 | $112,743 | $134,023 | $122,926 |
| Total Liabilities And Equity | $146,790 | $165,233 | $185,298 | $202,635 | $220,300 |